ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.042,00
0,18%
S&P 500
6.049,24
0,88%
Dow Jones
44.025,81
1,24%
Euro vs US Dollar
1,04175
0,11%
Bitcoin
105.876,97
-0,28%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Vereinigtes Königreich
  5. LSE

  6. Fusion Antibodies Plc (FAB) Börsenkurse

Fusion Antibodies Plc

Fusion Antibodies Plc (FAB)

First Trust Multi Cap Value AlphaDEX Fund
9,15
0,05
(0,55%)
Geschlossen 22 Januar 5:30PM
Verzögert um 15 Minuten

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
9,15
Gebot
8,80
Fragen
9,50
Volumen
661.393
9,10 Tagesbereich 9,25
2,90 52-Wochen-Bereich 11,75
Marktkapitalisierung
8,726M
Handelsende
9,10
Handelsbeginn
9,10
Letzte Trade
4
@
9.29
(O)
Letzter Handelszeitpunkt
Finanzvolumen
62.832p
VWAP
9,50
Durchschnittliches Volumen (3 Mio.)
1.576.970
Ausgegebene Aktien
95.365.564
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-3,93
Gewinn pro Aktie (EPS)
-0,02
Erlöse
1,14M
Nettogewinn
-2,23M

Über Fusion Antibodies Plc

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.fusionantibodies.com
Hauptsitz
Belfast, Gbr
Gegründet
-
Fusion Antibodies Plc is listed in the Pharmaceutical Preparations sector of the Londoner Börse with ticker FAB. The last closing price for Fusion Antibodies was 9,10p. Over the last year, Fusion Antibodies shares have traded in a share price range of 2,90p to 11,75p.

Fusion Antibodies currently has 95.365.564 shares in issue. The market capitalisation of Fusion Antibodies is £8,68 million. Fusion Antibodies has a price to earnings ratio (PE ratio) of -3.93.

FAB Neueste Nachrichten

Weitere Nachrichten

Fusion Antibodies receives approval of grant funding application

Fusion Antibodies PLC on Wednesday announced the approval of a grant funding application to The Northern Ireland Prec ...

04 Dezember 2024
Alliance News

Fusion Antibodies PLC Approval of Grant Funding Application

Fusion Antibodies PLC 04 December 2024   The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

04 Dezember 2024
RNS Regulatory News

Fusion Antibodies interim loss narrows as revenue more than doubles

Fusion Antibodies PLC on Tuesday said its loss narrowed in the first half of its current financial year, as revenue m ...

19 November 2024
Alliance News

Fusion Antibodies PLC Half-year Report

Fusion Antibodies PLC 19 November 2024   The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

19 November 2024
RNS Regulatory News

Fusion Antibodies PLC Director/PDMR Shareholding

Fusion Antibodies PLC 16 October 2024   16 October 2024    Fusion Antibodies plc ("Fusion" or the "Company")   Director/PDMR Shareholding   Fusion Antibodies plc (AIM: FAB), specialists in...

16 Oktober 2024
RNS Regulatory News

Fusion Antibodies PLC Issue of shares to non-executive directors

Fusion Antibodies PLC 16 October 2024   The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

16 Oktober 2024
RNS Regulatory News

IN BRIEF: Fusion Antibodies expects interim revenue to double

PLC - Belfast-based contract researcher that provides discovery, design and optimisation services for therapeutic ant ...

08 Oktober 2024
Alliance News

Fusion Antibodies PLC Result of AGM

Fusion Antibodies PLC 08 October 2024     Fusion Antibodies plc ("Fusion" or the "Company")   Result of AGM   Fusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery...

08 Oktober 2024
RNS Regulatory News

Fusion Antibodies PLC AGM statement and trading update

Fusion Antibodies PLC 08 October 2024   The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

08 Oktober 2024
RNS Regulatory News

Fusion Antibodies PLC Block admission six monthly return

Fusion Antibodies PLC 02 October 2024   2 October 2024    Fusion Antibodies plc ("Fusion" or the "Company")   Block admission six monthly return   Fusion Antibodies plc (AIM: FAB), specialists...

02 Oktober 2024
RNS Regulatory News
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.1-1.081081081089.259.257.757780498.45060409DE
42.1530.7142857143711.756.8218622039.14518859DE
124.9115.2941176474.2511.753.9515769706.94543811DE
266190.4761904763.1511.752.913516925.53022989DE
521.926.20689655177.2511.752.912668214.73925073DE
156-100.85-91.68181818181101102.97507916.18576386DE
260-83.35-90.108108108192.52502.946544910.80632515DE

FAB - Frequently Asked Questions (FAQ)

What is the current Fusion Antibodies share price?
The current share price of Fusion Antibodies is 9,15p
How many Fusion Antibodies shares are in issue?
Fusion Antibodies has 95.365.564 shares in issue
What is the market cap of Fusion Antibodies?
The market capitalisation of Fusion Antibodies is GBP 8,68M
What is the 1 year trading range for Fusion Antibodies share price?
Fusion Antibodies has traded in the range of 2,90p to 11,75p during the past year
What is the PE ratio of Fusion Antibodies?
The price to earnings ratio of Fusion Antibodies is -3,93
What is the cash to sales ratio of Fusion Antibodies?
The cash to sales ratio of Fusion Antibodies is 7,69
What is the reporting currency for Fusion Antibodies?
Fusion Antibodies reports financial results in GBP
What is the latest annual turnover for Fusion Antibodies?
The latest annual turnover of Fusion Antibodies is GBP 1,14M
What is the latest annual profit for Fusion Antibodies?
The latest annual profit of Fusion Antibodies is GBP -2,23M
What is the registered address of Fusion Antibodies?
The registered address for Fusion Antibodies is 1 SPRINGBANK ROAD, SPRINGBANK INDUSTRIAL ESTATE, DUNMURRY, BELFAST, BT17 0QL
What is the Fusion Antibodies website address?
The website address for Fusion Antibodies is www.fusionantibodies.com
Which industry sector does Fusion Antibodies operate in?
Fusion Antibodies operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
NTOGNostra Terra Oil And Gas Company Plc
0,043p
(36,51%)
524,2M
BSFABsf Enterprise Plc
3,375p
(35,00%)
13,75M
STBSecure Trust Bank Plc
465,00p
(33,62%)
929,66k
TIATialis Essential It Plc
26,50p
(23,26%)
105,62k
CBGClose Brothers Group Plc
298,40p
(21,90%)
4,6M
NTQEnteq Technologies Plc
1,25p
(-23,31%)
3,22M
BANKFiinu Plc
8,625p
(-15,85%)
21,19M
TIRTiger Royalties And Investments Plc
0,135p
(-15,63%)
75,44M
RCGHRc365 Holding Plc
1,80p
(-14,29%)
1,7M
INDIIndus Gas Limited
7,80p
(-13,33%)
214,66k
NTVONativo Resources Plc
0,0021p
(0,00%)
2,71B
PREMPremier African Minerals Limited
0,026p
(-3,70%)
623,1M
NTOGNostra Terra Oil And Gas Company Plc
0,043p
(36,51%)
524,2M
TRPTower Resources Plc
0,0305p
(0,00%)
504,66M
SYMESupply@me Capital Plc
0,003p
(-3,23%)
469,16M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

LSE
FAB
Fusion Antibodies
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten